You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selective Estrogen Receptor Modulator

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic ER+ Breast Cancer Trial in United States (TTC-352)

Completed
  • Metastatic ER+ Breast Cancer
  • Scottsdale, Arizona
  • +3 more
Aug 8, 2020

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

Not yet recruiting
  • Breast Cancer
  • Beijing, Benjing, China
  • +2 more
Dec 30, 2022

Metastatic Breast Cancer Trial in United States (Enobosarm & Abemaciclib Combo, non-steroidal AI, or steroidal AI (exemestane

Recruiting
  • Metastatic Breast Cancer
  • Enobosarm & Abemaciclib Combo
  • non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
  • Chandler, Arizona
  • +29 more
Feb 1, 2023

Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor Trial in Gent, Leuven, Liège (Abemaciclib, Letrozole)

Not yet recruiting
  • Low Grade Serous Ovarian Carcinoma
  • Adult Type Granulosa Cell Tumor
  • Gent, Oost-Vlaanderen, Belgium
  • +2 more
May 12, 2023

Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

Not yet recruiting
  • Breast Cancer
  • +8 more
  • (no location specified)
Feb 9, 2023

Ischemia Reperfusion Injury Trial in Philadelphia (Conjugated Estrogen, Normal saline)

Recruiting
  • Ischemia Reperfusion Injury
  • Conjugated Estrogen
  • Normal saline
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 22, 2022

Perimenopause-Related Mood and Behavioral Disorders

Recruiting
  • Mood Disorder
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    MDD (MDD) Trial (HS-10353 30mg oral capsules, HS-10353 50mg oral capsules, Placebo for HS-10353 30mg capsules)

    Not yet recruiting
    • Major Depressive Disorder (MDD)
    • HS-10353 30mg oral capsules
    • +3 more
    • (no location specified)
    Jul 10, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • Prognostic Stage IV Breast Cancer AJCC v8
    • Pembrolizumab
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 5, 2023

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    Metastatic Breast Cancer Trial in United States (Enzalutamide, Mifepristone, TPC)

    Recruiting
    • Metastatic Breast Cancer
    • Birmingham, Alabama
    • +5 more
    Oct 19, 2023

    Preemptive Analgesia, Dexmedetomidine, Ketamine Trial in Kafr Ash Shaykh (Dexmedetomidine, Ketamine, Magnesium sulphate)

    Not yet recruiting
    • Preemptive Analgesia
    • +5 more
    • Kafr Ash Shaykh, Karelsheikh, Egypt
      Karelsheikh University Hospital
    Apr 19, 2023

    Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

    Not yet recruiting
    • Breast Cancer
    • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
    • Ottawa, Ontario, Canada
    • +1 more
    Jul 22, 2023

    Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other, radiation)

    Active, not recruiting
    Has Results
    • Breast Adenocarcinoma
    • +6 more
    • Anniston, Alabama
    • +1230 more
    Jan 28, 2023

    Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States

    Recruiting
    • Stage 0 Breast Cancer AJCC v6 and v7
    • +10 more
    • Telemedicine
    • +6 more
    • Washington Township, New Jersey
    • +4 more
    Oct 18, 2022

    Irisin/FNDC5 Single Nucleotide Polymorphism in Breast Cancer

    Not yet recruiting
    • Breast Cancer
    • Genotyping
    • Sohag, Egypt
      Sohag university Hospital
    May 17, 2023

    Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Giredestrant,

    Recruiting
    • Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
    • Anchorage, Alaska
    • +386 more
    Jan 30, 2023

    Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,

    Recruiting
    • Glaucoma, Suspect
    • Aberration, Corneal Wavefront
    • Low dosage selective alpha-2 receptor agonists topical eyedrop
    • High dosage selective alpha-2 receptor agonists topical eyedrop
    • Banhā, QA, Egypt
      Ahmed Abdelshafy
    Jan 2, 2023

    A Post-Authorization, Long-term Study of Ozanimod Real-world

    Active, not recruiting
    • Multiple Sclerosis, Relapsing-Remitting
      • Bethesda, Maryland
        Evidera
      Oct 31, 2022

      Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States (drug, other, biological)

      Suspended
      • Metastatic Breast Carcinoma
      • Stage IV Breast Cancer AJCC v6 and v7
      • Corona, California
      • +6 more
      Sep 28, 2022

      Intracerebral Hemorrhage Trial (Fingolimod)

      Not yet recruiting
      • Intracerebral Hemorrhage
      • (no location specified)
      Oct 17, 2023

      Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

      Not yet recruiting
      • Advanced Breast Cancer
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Sep 12, 2022

      Infertility Trial in Barcelona (Ovarian Stimulation with CC+rFSH, Ovarian Stimulation with rFSH)

      Recruiting
      • Infertility
      • Ovarian Stimulation with CC+rFSH
      • Ovarian Stimulation with rFSH
      • Barcelona, Spain
        Salud de la Mujer Dexeus
      Jan 10, 2022

      Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast

      Not yet recruiting
      • Anatomic Stage IV Breast Cancer AJCC v8
      • +2 more
      • (no location specified)
      Nov 8, 2022